Antimicrobial, Antiparasitic, Anti-Inflammatory, and Cytotoxic Activities of Lopezia racemosa

Table 1

Antimicrobial activity of extracts and fractions of Lopezia racemosa expressed as MIC (𝜇g/mL).

	Bacteria						Fungi
	AB	BS	MRSA	MS	SA	SP	CA	CN	TR
HE	NA	NA	NA	NA	400	NA	NA	NA	NA
HF 9-10	NA	NA	400	NA	NA	NA	NA	NA	NA
HF 11–14b	NA	NA	40	NA	NA	NA	NA	NA	NA
HF 16	NA	400	400	NA	40	400	400	NA	NA
HF 18-19	NA	400	NA	NA	NA	400	NA	NA	NA
CE	400	400	40	NA	NA	NA	NA	NA	NA
CF 37–40	NA	NA	NA	400	400	NA	NA	NA	NA
CF 48–50	NA	NA	NA	NA	NA	NA	NA	NA	10
ME	NA	NA	NA	NA	NA	400	NA	NA	NA
MF 17	NA	400	400	NA	400	NA	400	400	NA
MF 20–24	NA	NA	400	NA	400	NA	NA	NA	NA
MF 28–36	NA	NA	40	400	NA	NA	NA	NA	40
Reference	0.1 (Ak)	15 (Ak)	60 (G)	0.7 (R)	1 (G)	(0.7) (Ap)	2 (A)	2 (A)	ND

AB: Acinetobacter baumannii; BS: Bacillus subtilis; MRSA: methicillin-resistant Staphylococcus aureus; MS: Mycobacterium smegmatis; SA: Staphylococcus aureus; SP: Streptococcus pyogenes; CA: Candida albicans; CN: Cryptococcus neoformans; TR: Trichophyton rubrum. NA: no activity detected; HE: hexane extract; CE: chloroform extract; ME: methanol extract; HF: hexanic fraction; CF: chloroformic fraction; MF: methanolic fraction. Experiments were performed in triplicate. A: amphotericin; Ak: amikacin; Ap: ampicillin; G: gentamicin; R: rifampicin; ND: no determined.